What is PCLOF stock price today?

PCLOF (Pharmacielo Ltd) stock is trading at $0.04 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PCLOF stock going up or down today?

PCLOF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PCLOF stock now?

The decision to buy PCLOF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PCLOF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PCLOF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PCLOF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PCLOF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PCLOF's P/E ratio?

P/E ratio data for PCLOF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PCLOF's market cap?

PCLOF (Pharmacielo Ltd) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is PCLOF's price to book ratio?

PCLOF trades at a price-to-book (P/B) ratio of 13.98, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PCLOF pay dividends?

PCLOF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PCLOF's dividend yield?

PCLOF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PCLOF stock a good long-term investment?

PCLOF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PCLOF's revenue growth rate?

PCLOF has shown revenue growth of -0.5% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

PCLOF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in PCLOF?

Key risks for PCLOF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PCLOF compare to its competitors?

Compare PCLOF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PCLOF's performance and positioning.

What is PCLOF's stock price target for 2026?

Our AI model provides price targets for PCLOF based on fundamental analysis: Bull case $0.05 (+30%), Base case $0.04 (+15%), Bear case $0.03 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PCLOF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PCLOF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PCLOF's next earnings report?

PCLOF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PCLOF - Pharmacielo Ltd

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.04

+$0.00 (+0.00%)

About Pharmacielo Ltd

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.

PCLOF Key Statistics

Market Cap

$7.60M

P/B Ratio

13.98

EPS

$-0.04

Revenue Growth

-0.5%

Profit Margin

-2.7%

How PCLOF Compares to Peers

PCLOF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PCLOF(This stock)	$7.60M	N/A	-0%	-2.7%	-
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
JNJJohnson &	$565.22B	21.3	0%	0.2%	vs JNJ
PFEPfizer Inc	$154.84B	20.0	-0%	0.1%	vs PFE
MRKMerck &	$285.46B	15.8	0%	0.3%	vs MRK
ABBVAbbvie Inc	$369.65B	88.6	0%	0.1%	vs ABBV

Pharmacielo Ltd Company Information

Headquarters: 82 Richmond Street East, Toronto, ON, Canada, M5C 1P1, undefined
Website: www.pharmacielo.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Data Updated: April 18, 2026 at 7:46 AM EDT

Ready to invest in PCLOF?

Commission-free trading available. Affiliate links.

Upcoming Events for PCLOF

Dashboard

Enter a ticker to analyze